Suchergebnisse - "van de Ven, Rieneke"
-
1
The Immune Microenvironment in Head and Neck Squamous Cell Carcinoma: on Subsets and Subsites
ISSN: 1523-3790, 1534-6269, 1534-6269Veröffentlicht: New York Springer US 01.08.2020Veröffentlicht in Current oncology reports (01.08.2020)“… Purpose To understand why some patients respond to immunotherapy but many do not, a clear picture of the tumor microenvironment (TME) of head and neck squamous …”
Volltext
Journal Article -
2
Targeting C‐type lectin receptors: a high‐carbohydrate diet for dendritic cells to improve cancer vaccines
ISSN: 0741-5400, 1938-3673, 1938-3673Veröffentlicht: Bethesda, MD, USA Society for Leukocyte Biology 01.10.2017Veröffentlicht in Journal of leukocyte biology (01.10.2017)“… Review of in vivo targeting of tumor antigens to lectin receptors on antigen‐presenting cells using antibodies or ligands may improve the antitumor efficacy of …”
Volltext
Journal Article -
3
Commentary on differential impact of TIM-3 ligands on NK cell function
ISSN: 2051-1426, 2051-1426Veröffentlicht: England BMJ Publishing Group Ltd 11.07.2025Veröffentlicht in Journal for immunotherapy of cancer (11.07.2025)“… T-cell immunoglobin and mucin-domain containing molecule 3 (TIM-3) is an immune checkpoint receptor and a target for immune checkpoint blockers (ICBs) …”
Volltext
Journal Article -
4
Immunotherapy Goes Local: The Central Role of Lymph Nodes in Driving Tumor Infiltration and Efficacy
ISSN: 1664-3224, 1664-3224Veröffentlicht: Switzerland Frontiers Media S.A 01.03.2021Veröffentlicht in Frontiers in immunology (01.03.2021)“… Immune checkpoint blockade (ICB) has changed the therapeutic landscape of oncology but its impact is limited by primary or secondary resistance. ICB resistance …”
Volltext
Journal Article -
5
Hallmarks of a genomically distinct subclass of head and neck cancer
ISSN: 2041-1723, 2041-1723Veröffentlicht: London Nature Publishing Group UK 20.10.2024Veröffentlicht in Nature communications (20.10.2024)“… Cancer is caused by an accumulation of somatic mutations and copy number alterations (CNAs). Besides mutations, these copy number changes are key …”
Volltext
Journal Article -
6
Tumor-educated Tregs drive organ-specific metastasis in breast cancer by impairing NK cells in the lymph node niche
ISSN: 2211-1247, 2211-1247Veröffentlicht: Elsevier Inc 01.03.2022Veröffentlicht in Cell reports (Cambridge) (01.03.2022)“… Breast cancer is accompanied by systemic immunosuppression, which facilitates metastasis formation, but how this shapes organotropism of metastasis is poorly …”
Volltext
Journal Article -
7
Guidelines for preparation and flow cytometry analysis of human nonlymphoid tissue DC
ISSN: 0014-2980, 1521-4141, 1521-4141Veröffentlicht: Germany Wiley Subscription Services, Inc 01.01.2025Veröffentlicht in European journal of immunology (01.01.2025)“… This article is part of the Dendritic Cell Guidelines article series, which provides a collection of state‐of‐the‐art protocols for the preparation, phenotype …”
Volltext
Journal Article -
8
Author Correction: Hallmarks of a genomically distinct subclass of head and neck cancer
ISSN: 2041-1723, 2041-1723Veröffentlicht: London Nature Publishing Group UK 17.02.2025Veröffentlicht in Nature communications (17.02.2025)Volltext
Journal Article -
9
Glycan-Modified Melanoma-Derived Apoptotic Extracellular Vesicles as Antigen Source for Anti-Tumor Vaccination
ISSN: 2072-6694, 2072-6694Veröffentlicht: Switzerland 01.09.2019Veröffentlicht in Cancers (01.09.2019)“… Tumors that lack T cell infiltration are less likely to respond to immune checkpoint inhibition and could benefit from cancer vaccination for the initiation of …”
Volltext
Journal Article -
10
Lipo-Based Vaccines as an Approach to Target Dendritic Cells for Induction of T- and iNKT Cell Responses
ISSN: 1664-3224, 1664-3224Veröffentlicht: Switzerland Frontiers Media S.A 27.05.2020Veröffentlicht in Frontiers in immunology (27.05.2020)“… In this study we developed a liposome-based vaccine containing palmitoylated synthetic long peptides (SLP) and alpha galactosylceramide (αGC) to specifically …”
Volltext
Journal Article -
11
Glycan-Modified Apoptotic Melanoma-Derived Extracellular Vesicles as Antigen Source for Anti-Tumor Vaccination
ISSN: 2072-6694, 2072-6694Veröffentlicht: Basel MDPI AG 28.08.2019Veröffentlicht in Cancers (28.08.2019)“… Tumors that lack T cell infiltration are less likely to respond to immune checkpoint inhibition and could benefit from cancer vaccination for the initiation of …”
Volltext
Journal Article -
12
Exploring the impact of tertiary lymphoid structures maturity in NSCLC: insights from TLS scoring
ISSN: 1664-3224, 1664-3224Veröffentlicht: Switzerland Frontiers Media SA 20.09.2024Veröffentlicht in Frontiers in immunology (20.09.2024)“… Tertiary Lymphoid Structures (TLS) are lymphoid structures commonly associated with improved survival of cancer patients and response to immunotherapies …”
Volltext
Journal Article -
13
Exposure of CD34+ precursors to cytostatic anthraquinone-derivatives induces rapid dendritic cell differentiation: implications for cancer immunotherapy
ISSN: 0340-7004, 1432-0851, 1432-0851Veröffentlicht: Berlin/Heidelberg Springer-Verlag 01.02.2012Veröffentlicht in Cancer Immunology, Immunotherapy (01.02.2012)“… Appropriate activation of dendritic cells (DC) is essential for successful active vaccination and induction of cell-mediated immunity. The scarcity of …”
Volltext
Journal Article -
14
Editorial: Mechanisms of Lymphocyte Exclusion in the Tumor Microenvironment
ISSN: 1664-3224, 1664-3224Veröffentlicht: Switzerland Frontiers Media S.A 29.04.2022Veröffentlicht in Frontiers in immunology (29.04.2022)Volltext
Journal Article -
15
Comparative phenotypic and functional analysis of migratory dendritic cell subsets from human oral mucosa and skin
ISSN: 1932-6203, 1932-6203Veröffentlicht: United States Public Library of Science 13.07.2017Veröffentlicht in PloS one (13.07.2017)“… Antigen exposure to oral mucosa is generally thought to lead to immune tolerance induction. However, very little is known about the subset composition and …”
Volltext
Journal Article -
16
Comparative analysis of immune infiltrates in head and neck cancers across anatomical sites
ISSN: 2051-1426, 2051-1426Veröffentlicht: England BMJ Publishing Group Ltd 11.01.2024Veröffentlicht in Journal for immunotherapy of cancer (11.01.2024)“… BackgroundThe response rate to immune checkpoint inhibitors targeting programmed cell death 1 (PD-1) receptor is 13%–18% for patients with recurrent or …”
Volltext
Journal Article -
17
Richness for Tumor-Infiltrating B-Cells in the Oral Cancer Tumor Microenvironment Is a Prognostic Factor in Early-Stage Disease and Improves Outcome in Advanced-Stage Disease
ISSN: 2072-6694, 2072-6694Veröffentlicht: Switzerland MDPI AG 01.01.2025Veröffentlicht in Cancers (01.01.2025)“… Background/Objectives: Most studies on the interaction between the immune system and cancer focus on T-cells, whereas studies on tumor-infiltrating …”
Volltext
Journal Article -
18
NK Cell-Dependent Antibody-Mediated Immunotherapy Is Improved In Vitro and In Vivo When Combined with Agonists for Toll-like Receptor 2 in Head and Neck Cancer Models
ISSN: 1422-0067, 1661-6596, 1422-0067Veröffentlicht: Switzerland MDPI AG 14.10.2021Veröffentlicht in International journal of molecular sciences (14.10.2021)“… The immunosuppressive character of head and neck cancers may explain the relatively low response rates to antibody therapy targeting a tumor antigen, such as …”
Volltext
Journal Article -
19
Selectively hampered activation of lymph node-resident dendritic cells precedes profound T cell suppression and metastatic spread in the breast cancer sentinel lymph node
ISSN: 2051-1426, 2051-1426Veröffentlicht: London BioMed Central 22.05.2019Veröffentlicht in Journal for immunotherapy of cancer (22.05.2019)“… Background Immune regulated pathways influence both breast cancer (BrC) development and response to (neo)adjuvant chemotherapy. The sentinel lymph node (SLN), …”
Volltext
Journal Article -
20
Immune cell topography of head and neck cancer
ISSN: 2051-1426, 2051-1426Veröffentlicht: England BMJ Publishing Group Ltd 24.07.2024Veröffentlicht in Journal for immunotherapy of cancer (24.07.2024)“… BackgroundApproximately 50% of head and neck squamous cell carcinomas (HNSCC) recur after treatment with curative intent. Immune checkpoint inhibitors are …”
Volltext
Journal Article